News | Nanologica

Nanologica tar order från insulintillverkare för produktion

11 August, 2022

Nanologica AB (publ) har tagit en order på bolagets silika för preparativ kromatografi för utvärdering i produktionsskala, från en av världens största tillverkare av insulin. Om produkterna motsvarar kundens förväntningar förväntar sig bolaget kommersiella leveranser inom ett år. Nanologica har bearbetat kunder inom preparativ kromatografi sedan 2016 och ett flertal kunder har framgångsrikt utvärderat bolagets silika för preparativ kromatografi, NLAB Saga®, i olika steg. Nanologica har under en längre tid fört dialog med en av

Nanologica Expands Management Team for Increased Focus on Chromatography

10 August, 2022

Nanologica AB (publ) has expanded its management team with Katarina Alenäs, SVP Chromatography, as part of intensifying the company’s efforts within preparative chromatography. Katarina Alenäs took up her position as SVP Chromatograhy at Nanologica in the beginning of March, and most recently came from a role as Business Team Manager Sweden and Finland, Country General Manager Sweden and chairman of the board of Agilent Technologies Sweden AB. Katarina has a solid background and a strong

Nanologica utökar ledningsgruppen för stärkt fokus på kromatografi

10 August, 2022

Nanologica AB (publ) utökar sin ledningsgrupp med Katarina Alenäs, SVP Chromatography, som ett led i att bolagets satsning på preparativ kromatografi intensifieras. Katarina Alenäs tillträdde sin position som SVP Chromatography hos Nanologica i början av mars och kom närmast från en roll som Business Team Manager Sweden and Finland, Country General Manager Sweden samt styrelseordförande i Agilent Technologies Sweden AB. Katarina har en gedigen bakgrund och ett starkt nätverk inom kromatografiområdet, ett område hon har

5 quick questions with Chunfang Zhou

9 August, 2022

Chunfang Zhou, Sales Manager China, Nanologica AB Who are you? My name is Chunfang Zhou and I am Nanologica’s Sales Manager in China. I am originally from China where I studied Chemical Engineering and did my PhD in Physical Chemistry. I also have a Post Doc from the University of Aveiro in Portugal. I have worked with nanoporous silica for more than 20 years, both within drug delivery and in chromatography. What is your current

5 Quick Questions with PK Dutta

30 June, 2022

P.K. DUTTA, Ph.D., SVP Sales Nanologica AB Who are you? I am a Molecular Biologist by training. I have spent most of my career dealing with large scale silica based industrial purification of peptides and small molecules. Before joining Nanologica, I held leadership and strategic roles for global silica brands like Waters, Kromasil and YMC. I am very honored to be part of the Nanologica Business Development Team, establishing a more significant presence in the

Analytica in Munich

14 June, 2022

Next week from June 21 to 24, Nanologica will be at Analytica in Munich! Analytica is the leading industry event for analytics, laboratory technology and biotechnology. With 1,200 exhibitors, 36,000 visitors and 55,000 square meters of exhibition space, Analytica is the largest trade fair for analysis, laboratory technology and biotechnology in the world. As the industry’s definitive forum, Analytica gives visitors a comprehensive market overview and information about the latest developments in laboratory technology, analysis

About us

Nanologica is a Swedish life science group that offers advanced solutions in the development, manufacture and purification of pharmaceutical substances. By combining expertise in materials science, nanotechnology, and chemical process development, with services in contract development and manufacturing, Nanologica provides an integrated platform that supports the entire value chain from early development to commercial production of pharmaceutical substances. Nanologica’s offering enables efficient and scalable production of drug substances, with particular strength within complex molecules and peptide-based drugs, such as treatments for diabetes and obesity. The company positions itself as a long-term partner to the pharmaceutical industry, with the goal of enabling more patients around the world to have access to life-saving treatments and cost-effective medicines. The Group has about 70 employees and is headquartered in Södertälje. Nanologica’s share (ticker NICA) has been listed on Nasdaq Stockholm’s main market since 2022.

Latest news

Categories

News archive